Emergent BioSolutions
EBS
$2.39
Share price
11.68%
Change (1 day)
-79.76%
Change (1 year)
Categories
Market capitalization of Emergent BioSolutions (EBS)
Market cap: $0.12 Billion
As of December 2023 Emergent BioSolutions has a market cap of $0.12 Billion. This makes Emergent BioSolutions the world's 6837th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Emergent BioSolutions from 2006 to 2023
End of year Market Cap
| Year | Market cap | Change |
|---|---|---|
| 2023 | $0.12 B | -78.98% |
| 2022 | $0.58 B | -74.81% |
| 2021 | $2.33 B | -50.75% |
| 2020 | $4.74 B | 70.25% |
| 2019 | $2.78 B | -8.1% |
| 2018 | $3.03 B | 30.9% |
| 2017 | $2.31 B | 74.34% |
| 2016 | $1.32 B | -15.65% |
| 2015 | $1.57 B | 53.55% |
| 2014 | $1.02 B | 21.95% |
| 2013 | $0.84 B | 46.34% |
| 2012 | $0.57 B | -4.97% |
| 2011 | $0.60 B | -26.29% |
| 2010 | $0.82 B | 96.03% |
| 2009 | $0.41 B | -46.37% |
| 2008 | $0.78 B | 418.97% |
| 2007 | $0.15 B | -51.12% |
| 2006 | $0.30 B |
End of Day market cap according to different sources
On Dec 1st, 2023 the market cap of Emergent BioSolutions was reported to be:
$0.12 Billion
$0.12 Billion
$0.12 Billion
$0.12 Billion
Market capitalization for similar companies or competitors
| Name | Market cap | Market cap differencediff. | Country |
|---|---|---|---|
 Pfizer PFE | $163.23 B | 131,736.04% | 🇺🇸 USA |
 Merck MRK | $262.16 B | 211,636.71% | 🇺🇸 USA |
 GlaxoSmithKline GSK | $74.87 B | 60,373.73% | 🇬🇧 UK |
 Soligenix SNGX | $7.57 M | -93.88% | 🇺🇸 USA |
 SIGA Technologies SIGA | $0.39 B | 222.10% | 🇺🇸 USA |
 Celldex Therapeutics CLDX | $1.75 B | 1,314.28% | 🇺🇸 USA |
 Teva Pharmaceutical Industries TEVA | $10.90 B | 8,705.67% | 🇮🇱 Israel |